Page last updated: 2024-10-27

gentamicin and Diabetic Glomerulosclerosis

gentamicin has been researched along with Diabetic Glomerulosclerosis in 4 studies

Gentamicins: A complex of closely related aminoglycosides obtained from MICROMONOSPORA purpurea and related species. They are broad-spectrum antibiotics, but may cause ear and kidney damage. They act to inhibit PROTEIN BIOSYNTHESIS.

Research Excerpts

ExcerptRelevanceReference
" This paper reports the results of studies concerning carnosine's role in kidney diseases, particularly in ischemia/reperfusion induced acute renal failure, diabetic nephropathy, gentamicin-induced nephrotoxicity and also in blood pressure regulation."8.88[Carnosine, carnosinase and kidney diseases]. ( Kiliś-Pstrusińska, K, 2012)
" This paper reports the results of studies concerning carnosine's role in kidney diseases, particularly in ischemia/reperfusion induced acute renal failure, diabetic nephropathy, gentamicin-induced nephrotoxicity and also in blood pressure regulation."4.88[Carnosine, carnosinase and kidney diseases]. ( Kiliś-Pstrusińska, K, 2012)
"Thrombosis was defined as the inability to use catheter at a blood flow of 200 ml/min despite intraluminal thrombolysis."2.72Tunneled catheters' outcome optimization among diabetics on dialysis through antibiotic-lock placement. ( Abu-Oun, BA; Al-Ghamdi, AA; Al-Hafiz, A; Hussain, SM; Naguib, M; Panhotra, BR; Saxena, AK; Sundaram, DS; Venkateshappa, CK, 2006)
"Gentamicin induced increase in lipid peroxides, decrease in glutathione and activities of antioxidant enzymes in the kidney, and increase in blood creatinine, and urea concentrations were significantly countered by nigerloxin treatment."1.40Fungal metabolite nigerloxin ameliorates diabetic nephropathy and gentamicin-induced renal oxidative stress in experimental rats. ( Srinivasan, K; Suresha, BS, 2014)
" The pharmacokinetic parameters of gentamicin [volume of distribution (Vd), clearance (CL), elimination rate constant (K), and half life of elimination (t((1/2)))] were studied before hemodialysis in 20 non-diabetic patients (controls) and 20 diabetic patients, in addition to its hemodialysis clearance."1.35Pharmacokinetics of gentamicin in hemodialysis patients: a comparative study between diabetic and non-diabetic patients. ( Al-Homrany, MA; El Sherif, AK; Irshaid, YM; Omar, HA, 2009)

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (50.00)29.6817
2010's2 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Suresha, BS1
Srinivasan, K1
Al-Homrany, MA1
Irshaid, YM1
El Sherif, AK1
Omar, HA1
Kiliś-Pstrusińska, K1
Saxena, AK1
Panhotra, BR1
Sundaram, DS1
Al-Hafiz, A1
Naguib, M1
Venkateshappa, CK1
Abu-Oun, BA1
Hussain, SM1
Al-Ghamdi, AA1

Reviews

1 review available for gentamicin and Diabetic Glomerulosclerosis

ArticleYear
[Carnosine, carnosinase and kidney diseases].
    Postepy higieny i medycyny doswiadczalnej (Online), 2012, Apr-20, Volume: 66

    Topics: Acute Kidney Injury; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Carnosine; Diabetic N

2012

Trials

1 trial available for gentamicin and Diabetic Glomerulosclerosis

ArticleYear
Tunneled catheters' outcome optimization among diabetics on dialysis through antibiotic-lock placement.
    Kidney international, 2006, Volume: 70, Issue:9

    Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Antibiotic Prophylaxis; Bacterial Infections;

2006

Other Studies

2 other studies available for gentamicin and Diabetic Glomerulosclerosis

ArticleYear
Fungal metabolite nigerloxin ameliorates diabetic nephropathy and gentamicin-induced renal oxidative stress in experimental rats.
    Naunyn-Schmiedeberg's archives of pharmacology, 2014, Volume: 387, Issue:9

    Topics: Aldehyde Reductase; Animals; Anti-Bacterial Agents; Aspergillus niger; Benzoates; Blood Glucose; Cre

2014
Pharmacokinetics of gentamicin in hemodialysis patients: a comparative study between diabetic and non-diabetic patients.
    International urology and nephrology, 2009, Volume: 41, Issue:3

    Topics: Adult; Anti-Bacterial Agents; Diabetic Nephropathies; Female; Gentamicins; Humans; Kidney Failure, C

2009